Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
Journal: Clinical breast cancer
Published: September 10, 2020
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: August 03, 2017
Project connect online: randomized trial of an internet-based program to chronicle the cancer experience and facilitate communication.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 14, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026